Search results for "heart disease"

showing 10 items of 489 documents

Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF).

2009

Accumulating evidence suggests that inflammation plays an important role in the acute phase of ischemic stroke. CD40 L is a well recognized atherosclerotic inflammatory marker, whereas recent evidence suggests a pro-inflammatory role of Fetuin-A. To analyze the role of an inflammatory marker such as CD40 L and of a candidate pro-inflammatory marker such as Fetuin-A in acute stroke we evaluated their serum levels in subjects with acute ischemic stroke and their possible association with other laboratory and clinical variables. MATERIALS AND METHODS: We enrolled 107 consecutive patients with a diagnosis of acute ischemic stroke admitted to the Internal Medicine Department at the University of…

Malemedicine.medical_specialtyHeart diseaseImmuno-inflammatory predictorCentral nervous system diseaseVon Willebrand factorpatients with chronic non-valvular atrial fibrillationInternal medicineAtrial FibrillationMedicineHumansInterleukin 6StrokeAgedbiologyReceiver operating characteristicbusiness.industryVascular diseaseAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurgeryStrokeChronic Diseasebiology.proteinCardiologypredictors of strokeFemalebusinessEpidemiologic MethodsBiomarkers
researchProduct

Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease.

2009

To evaluate the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2-5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function.All patients underwent echocardiographic examination. Patients on stage 1 CKD, dialysis treatment, or with cardiovascular diseases were excluded.LVH was observed in 47.1% of patients with CKD and in 31.14% of essential hypertensive patients (P0.0001). We found increasingly higher left ventricular diameters, thicknesses, and mass from stage 2 to 5 CKD. Distribution of concentric and eccentric LVH was not different between the two groups. H…

Malemedicine.medical_specialtyHeart diseasePhysiologyRenal functionGuidelines as TopicLeft ventricular hypertrophyMuscle hypertrophyElectrolytesCatecholaminesInternal medicineReninInternal MedicinemedicineDiabetes MellitusPrevalenceHumansLeft ventricular geometrycardiovascular diseasesStage (cooking)AldosteroneAgedbusiness.industryCase-control studyBlood Pressure DeterminationMiddle Agedmedicine.diseaseEchocardiography DopplerItalyCase-Control StudiesCreatinineChronic DiseaseHypertensionCardiologyRegression AnalysisFemaleHypertrophy Left VentricularKidney DiseasesNefropatie croniche ipertrofia ventricolare sinistra ipertensione arteriosaCardiology and Cardiovascular MedicinebusinessKidney diseaseGlomerular Filtration RateJournal of hypertension
researchProduct

Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM

2004

AIM: To evaluate the predictive role of hs-CRP and fibrinogen for cardio- and cerebrovascular events in a population of patients with type 2 diabetes. METHODS: We studied 156 patients with type 2 diabetes, mean age 66+10 years, and 156 sex and age matched control subjects. Patients underwent physical examination, EKG, measurement of body mass index and blood pressure. A blood sample was drawn to evaluate glycaemia, total and HDL/LDL cholesterol, triglycerides, high sensitive C-reactive protein (hs-CRP), fibrinogen. Finally, patients underwent an ecocolordoppler examination of the common carotid arteries until the bifurcation. In a follow-up of 5+/-1.2 years we evaluated the following events…

Malemedicine.medical_specialtyHeart diseasePopulationType 2 diabetesFibrinogenRisk FactorsInternal medicineDiabetes mellitusPrevalenceHumansMedicineMyocardial infarctioneducationAgededucation.field_of_studyChi-Square Distributionbiologybusiness.industryUnstable anginaC-reactive proteinFibrinogenAcute myocardial infarction C-reactive protein Diabetes mellitusmedicine.diseaseCerebrovascular DisordersC-Reactive ProteinEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesCase-Control Studiesbiology.proteinCardiologyFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugInternational Journal of Cardiology
researchProduct

Microvascular perfusion 1 week and 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging

2006

To characterise the evolution of myocardial perfusion during the first 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging (CMR) and determine its significance.Prospective cohort design.Single-centre study in a teaching hospital in Spain.40 patients with a first ST-elevation myocardial infarction, single-vessel disease and thrombolysis in myocardial infarction (TIMI) grade 3 flow (stent in 33 patients) underwent rest and low-dose dobutamine CMR 7 (SD 1) and 184 (SD 11) days after infarction. Microvascular perfusion was assessed at rest by visual assessment and quantitative analysis of first-pass perfusion CMR. Of the 640 segments, 290 segme…

Malemedicine.medical_specialtyHeart diseaseSystoleMyocardial InfarctionInfarctionPerfusion scanningCardiovascular MedicineMagnetic resonance angiographyCohort StudiesNecrosisCoronary circulationDiastoleCoronary CirculationInternal medicineHumansMedicineProspective Studiescardiovascular diseasesMyocardial infarctionmedicine.diagnostic_testbusiness.industryMicrocirculationMyocardiumMiddle Agedmedicine.diseasemedicine.anatomical_structurecardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessPerfusionMagnetic Resonance AngiographyTIMIHeart
researchProduct

Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients agedor=65 years. The FAPRES trial.

2010

Introduction and objectives. Age and arterial hypertension are two of the main factors associated with atrial fibrillation and an increased risk of embolism. The objective of this study was to determine the prevalence of atrial fibrillation and the extent of antithrombotic use in hypertensive patients aged ≥65 years in the Spanish region of Valencia. Methods. Each study investigator enrolled the first three hypertensive patients aged ≥65 years who came for a consultation on the first day of each week for 5 weeks. Each patient’s risk factors, history of cardiovascular disease, CHADS2 score and medical treatment were noted and an ECG was recorded. Data were analyzed centrally. A patient was r…

Malemedicine.medical_specialtyHeart diseasebusiness.industryMedical recordRenal functionAtrial fibrillationGeneral MedicineDiseasemedicine.diseaseEmbolismFibrinolytic AgentsInternal medicineAntithromboticAtrial FibrillationHypertensionmedicineCardiologyPrevalenceHumansSinus rhythmFemalecardiovascular diseasesbusinessAgedRevista espanola de cardiologia
researchProduct

Effect of antibiotic treatment on vegetation size and complication rate in infective endocarditis

1997

Background: Infective endocarditis is associated with significant morbidity and mortality, with valvular destruction, and with congestive heart failure. Embolic events are more common in patients with echocardiographically discernible vegetations, especially when vegetations are >10 mm in diameter. Hypothesis: The objective of the study was to follow vegetation morphology during native valve endocarditis, to compare it with the clinical course and antibiotic treatment chosen, and to evaluate whether the impact on vegetation size and complication rate of antibiotic regimens differed in patients with positive and negative blood cultures. Methods: The effect of different antibiotic regimes on …

Malemedicine.medical_specialtyHeart diseasemedicine.drug_classAortic Valve InsufficiencyAntibioticsThromboembolismmedicineHumansEndocarditisClinical InvestigationSurvival rateGram-Positive Bacterial InfectionsRetrospective StudiesNative Valve Endocarditisbusiness.industryMitral Valve InsufficiencyEndocarditis BacterialGeneral MedicineMiddle Agedmedicine.diseaseAnti-Bacterial AgentsCerebral AngiographySurgerySurvival RateTreatment OutcomeInfective endocarditisDrug Therapy CombinationFemaleMorbiditymedicine.symptomGram-Negative Bacterial InfectionsCardiology and Cardiovascular MedicinebusinessVegetation (pathology)ComplicationEchocardiography TransesophagealFollow-Up StudiesClinical Cardiology
researchProduct

Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depression.

2018

Patients with coronary heart disease (CHD) suffer from physical limitations, but also from psychological distress. Natriuretic peptides may be involved in the neurobiological processes that modulate psychological adaptation, as they are increased in heart disease and seem to have an anxiolytic-like function. Longitudinal data on this association are scarce.To assess the relationship between NT-proBNP and anxiety (Hospital Anxiety and Depression Scale (HADS)), we used secondary data from a multicenter trial from baseline to 24 months. Patients (N = 308, 80.8% male, mean age 60.1 years) had stable CHD and moderate levels of depression (HADS ≥8).Multiple linear regression adjusted for age, sex…

Malemedicine.medical_specialtyHeart diseasemedicine.drug_classDiseaseCoronary Artery DiseaseAnxietyHospital Anxiety and Depression ScaleCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineMulticenter trialNatriuretic Peptide BrainNatriuretic peptideMedicineHumanscardiovascular diseases030212 general & internal medicineLongitudinal StudiesDepression (differential diagnoses)Depressive Disorderbusiness.industryAnxiety ; Coronary Heart Disease ; Depression ; Natriuretic PeptideMiddle Agedmedicine.diseasePeptide FragmentsPsychotherapyPsychiatry and Mental healthClinical PsychologyAnxietyFemalemedicine.symptombusinesshormones hormone substitutes and hormone antagonists030217 neurology & neurosurgeryJournal of psychosomatic research
researchProduct

Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compe…

2011

INTRODUCTION: Hypertonic saline solution (HSS) and a moderate Na restriction plus high furosemide dose showed beneficial effects in compensated heart failure (HF), in short and long terms. The study was aimed to verify the effects of this combination on hospitalization time, readmissions and mortality in patients in New York Heart Association (NYHA) class III. METHOD: Chronic ischemic or nonischemic cardiomyopathy uncompensated patients with HF in NYHA III functional class with ejection fraction <40%, serum creatinine <2.5 mg/dL, blood urea nitrogen <60 mg/dL and reduced urinary volume were single-blind randomized in 2 groups: the first group received a 30-minute intravenous infusion of fur…

Malemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentDiuresisPatient ReadmissionFurosemideInternal medicinemedicineHumansInfusions IntravenousAgedAged 80 and overHeart FailureSaline Solution HypertonicEjection fractionbusiness.industrySodiumFurosemideGeneral MedicineDiet Sodium-RestrictedMiddle Agedmedicine.diseaseHyepertonic saline heart failure diureticsDiuresisSurgeryHospitalizationTreatment OutcomeHeart failureCirculatory systemCardiologyTonicityFemaleDiureticbusinessmedicine.drugThe American Journal of the Medical Sciences
researchProduct

Inflammatory pathways in patients with heart failure and preserved ejection fraction.

2008

Immune activation is well established in patients with chronic heart failure and reduced ejection fraction (HF and reduced EF) and is associated with an impaired prognosis. Patients with heart failure and preserved ejection fraction (HF and preserved EF) have an impaired prognosis as well. It is not known whether they have signs of immune activation.We studied patients with HF and preserved EF (n=17, NYHA II [n=7]/III [n=10]) and patients with HF and reduced EF (n=17 NYHA II [n=1]/III [n=16]) and 20 controls. Echocardiography demonstrated preserved ejection fraction (LVEF 59+/-9%), but LV hypertrophy in patients with preserved EF as compared with patients with reduced EF (LVEF 23+/-5%). We …

Malemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentHemodynamicsInflammationVentricular Function LeftInternal medicineNatriuretic Peptide BrainmedicineHumansIn patientReceptorAgedAged 80 and overHeart FailureInflammationEjection fractionbusiness.industryStroke VolumeMiddle Agedmedicine.diseasePeptide FragmentsCytokineHeart failureCardiologyCytokinesFemalemedicine.symptomInflammation MediatorsCardiology and Cardiovascular MedicinebusinessSignal TransductionInternational journal of cardiology
researchProduct

Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease.

2010

Left ventricular hypertrophy (LVH) and diastolic dysfunction are very common in patients with chronic kidney disease (CKD). Aim of this study was to evaluate the impact of type 2 diabetes on LV geometry and diastolic function in hypertensive patients with CKD. We enrolled 288 Caucasian subjects with hypertension and CKD; of them, 112 had diabetes. Patients with cardiovascular (CV) diseases, glomerular filtration rate (GFR)60 ml min(-1) per 1.73 m(2), dialysis treatment and other major non-CV diseases were excluded. All patients underwent routine biochemical analyses and echocardiographic examination with tissue Doppler imaging (TDI). Patients with diabetes had significantly higher LV wall t…

Malemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentRenal functionType 2 diabetesComorbidityLeft ventricular hypertrophyInternal medicineDiabetes mellitusInternal MedicinemedicinePrevalenceHumansRenal Insufficiency ChronicDialysisAgedUltrasonographyheart diseasesVentricular Remodelingbusiness.industryMiddle Agedmedicine.diseaseleft ventricular hypertrophySurgeryBlood pressureDiabetes Mellitus Type 2diabeteHypertensionCardiologydiastolic dysfunctionFemaleHypertrophy Left Ventricularbusinesschronic kidney diseaseKidney diseaseGlomerular Filtration RateJournal of human hypertension
researchProduct